Cytek Biosciences, Inc.·Healthcare

Cytek Biosciences (NASDAQ: CTKB) outlined its recent product launches, geographic diversification, and expectations for 2026 during a presentation and fireside chat at TD Cowen's 42nd annual healthcare conference. CEO and Chairman Wenbin Jiang and CFO William McCombe discussed the company's installed base growth, the increasing contribution of recurring revenue streams, and how management is thinking about